Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells

Pancreatic cancer has a poor prognosis. New treatment options are urgently required to improve patient outcomes. One promising new class of anticancer drugs are synthetic histone deacetylase inhibitors (HDACi) which modulate chromatin structure and gene expression by blocking histone deacetylation....

Descripción completa

Detalles Bibliográficos
Autores principales: Moertl, Simone, Payer, Sarah, Kell, Rosemarie, Winkler, Klaudia, Anastasov, Natasa, Atkinson, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651299/
https://www.ncbi.nlm.nih.gov/pubmed/31269745
http://dx.doi.org/10.3390/ijms20133259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651299/
https://www.ncbi.nlm.nih.gov/pubmed/31269745
http://dx.doi.org/10.3390/ijms20133259

Ejemplares similares